|
MNP-1 protein, human
|
C114015 |
|
|
MNP-2 protein, human
|
C114016 |
|
|
feedback inhibitor of lactation, Capra hircus
|
C114017 |
|
|
1a-docosahexaenoyl mitomycin C
|
C114019 |
|
|
Dyslipidemias
|
D050171 |
[Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
] |
|
Genes, X-Linked
|
D050172 |
[Genes that are located on the X CHROMOSOME.
] |
|
beta-lactam synthetase
|
C114020 |
|
|
Genes, Y-Linked
|
D050173 |
[Genes that are located on the Y CHROMOSOME.
] |
|
ags1 protein, S pombe
|
C114021 |
|
|
Genetic Diseases, Y-Linked
|
D050174 |
[Genetic diseases that are linked to mutant ALLELES on the Y CHROMOSOME in humans (Y CHROMOSOME, HUMAN) or the Y chromosome in other species. Included here are animal models of human Y-linked diseases.
] |
|
MYCBP2 protein, human
|
C114022 |
|
|
Pansporablastina
|
D050175 |
[A suborder of FUNGI in the phylum MICROSPORIDIA, possessing a pansporoblastic membrane.
] |
|
Overweight
|
D050177 |
[A status with BODY WEIGHT that is above certain standard of acceptable or desirable weight. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal "over fat".
] |
|
Monoglycerides
|
D050178 |
[GLYCEROL esterified with a single acyl (FATTY ACIDS) chain.
] |
|
Clinical Laboratory Services
|
D064790 |
[Organized services provided by MEDICAL LABORATORY PERSONNEL for the purpose of carrying out CLINICAL LABORATORY TECHNIQUES used for the diagnosis, treatment, and prevention of disease.
] |
|
Desoxycorticosterone Acetate
|
D064791 |
[The 21-acetate derivative of desoxycorticosterone.
] |
|
Pragmatic Clinical Trials as Topic
|
D064792 |
[Works about randomized clinical trials that compare interventions in clinical settings and which look at a range of effectiveness outcomes and impacts.
] |
|
Teratogenesis
|
D064793 |
[The formation of CONGENITAL ABNORMALITIES.
] |
|
Lorajmine
|
D064794 |
[A monochloroacetyl derivative of ajmaline. It is a class Ia antiarrhythmic agent that is rapidly hydrolyzed to ajmaline by plasma and tissue esterases.
] |
|
phoA protein, E coli
|
C114089 |
|
